Logo image of HBAN

HUNTINGTON BANCSHARES INC (HBAN) Stock Fundamental Analysis

NASDAQ:HBAN - Nasdaq - US4461501045 - Common Stock - Currency: USD

16.06  +0.25 (+1.58%)

After market: 16.05 -0.01 (-0.06%)

Fundamental Rating

3

Taking everything into account, HBAN scores 3 out of 10 in our fundamental rating. HBAN was compared to 405 industry peers in the Banks industry. HBAN has a bad profitability rating. Also its financial health evaluation is rather negative. HBAN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

HBAN had positive earnings in the past year.
HBAN had a positive operating cash flow in the past year.
In the past 5 years HBAN has always been profitable.
Of the past 5 years HBAN 4 years had a positive operating cash flow.
HBAN Yearly Net Income VS EBIT VS OCF VS FCFHBAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

HBAN has a Return On Assets (0.76%) which is comparable to the rest of the industry.
With a Return On Equity value of 7.37%, HBAN perfoms like the industry average, outperforming 42.36% of the companies in the same industry.
Industry RankSector Rank
ROA 0.76%
ROE 7.37%
ROIC N/A
ROA(3y)1%
ROA(5y)0.85%
ROE(3y)10.17%
ROE(5y)8.4%
ROIC(3y)N/A
ROIC(5y)N/A
HBAN Yearly ROA, ROE, ROICHBAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

HBAN's Profit Margin of 21.22% is in line compared to the rest of the industry. HBAN outperforms 44.11% of its industry peers.
HBAN's Profit Margin has declined in the last couple of years.
HBAN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 21.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y8.21%
PM growth 5Y-3.17%
GM growth 3YN/A
GM growth 5YN/A
HBAN Yearly Profit, Operating, Gross MarginsHBAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

0

2. Health

2.1 Basic Checks

HBAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HBAN has more shares outstanding
The number of shares outstanding for HBAN has been increased compared to 5 years ago.
Compared to 1 year ago, HBAN has a worse debt to assets ratio.
HBAN Yearly Shares OutstandingHBAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
HBAN Yearly Total Debt VS Total AssetsHBAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

The Debt to FCF ratio of HBAN is 11.20, which is on the high side as it means it would take HBAN, 11.20 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 11.20, HBAN is not doing good in the industry: 72.18% of the companies in the same industry are doing better.
HBAN has a Debt/Equity ratio of 0.57. This is a neutral value indicating HBAN is somewhat dependend on debt financing.
HBAN's Debt to Equity ratio of 0.57 is on the low side compared to the rest of the industry. HBAN is outperformed by 78.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 11.2
Altman-Z N/A
ROIC/WACCN/A
WACC13.56%
HBAN Yearly LT Debt VS Equity VS FCFHBAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HBAN Yearly Current Assets VS Current LiabilitesHBAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for HBAN have decreased strongly by -10.71% in the last year.
HBAN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.32% yearly.
HBAN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.34%.
Measured over the past years, HBAN shows a quite strong growth in Revenue. The Revenue has been growing by 9.61% on average per year.
EPS 1Y (TTM)-10.71%
EPS 3Y-1.55%
EPS 5Y-0.32%
EPS Q2Q%13.33%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y7.22%
Revenue growth 5Y9.61%
Sales Q2Q%13.63%

3.2 Future

Based on estimates for the next years, HBAN will show a small growth in Earnings Per Share. The EPS will grow by 6.00% on average per year.
The Revenue is expected to grow by 3.94% on average over the next years.
EPS Next Y13.92%
EPS Next 2Y13.3%
EPS Next 3Y13.25%
EPS Next 5Y6%
Revenue Next Year7.18%
Revenue Next 2Y6.69%
Revenue Next 3Y6.2%
Revenue Next 5Y3.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HBAN Yearly Revenue VS EstimatesHBAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
HBAN Yearly EPS VS EstimatesHBAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.85, HBAN is valued correctly.
HBAN's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 29.36. HBAN is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.28, which indicates a very decent valuation of HBAN.
HBAN's Price/Forward Earnings ratio is in line with the industry average.
HBAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.65.
Industry RankSector Rank
PE 12.85
Fwd PE 11.28
HBAN Price Earnings VS Forward Price EarningsHBAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of HBAN indicates a slightly more expensive valuation: HBAN is more expensive than 69.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.17
EV/EBITDA N/A
HBAN Per share dataHBAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

HBAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HBAN's earnings are expected to grow with 13.25% in the coming years.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y13.3%
EPS Next 3Y13.25%

6

5. Dividend

5.1 Amount

HBAN has a Yearly Dividend Yield of 3.78%.
Compared to an average industry Dividend Yield of 3.19, HBAN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.27, HBAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.78%

5.2 History

The dividend of HBAN has a limited annual growth rate of 5.35%.
HBAN has been paying a dividend for at least 10 years, so it has a reliable track record.
HBAN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)5.35%
Div Incr Years0
Div Non Decr Years15
HBAN Yearly Dividends per shareHBAN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

HBAN pays out 68.97% of its income as dividend. This is not a sustainable payout ratio.
HBAN's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP68.97%
EPS Next 2Y13.3%
EPS Next 3Y13.25%
HBAN Yearly Income VS Free CF VS DividendHBAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
HBAN Dividend Payout.HBAN Dividend Payout, showing the Payout Ratio.HBAN Dividend Payout.PayoutRetained Earnings

HUNTINGTON BANCSHARES INC

NASDAQ:HBAN (2/26/2025, 8:00:01 PM)

After market: 16.05 -0.01 (-0.06%)

16.06

+0.25 (+1.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-17 2025-01-17/bmo
Earnings (Next)04-17 2025-04-17/bmo
Inst Owners87.29%
Inst Owner Change-90.83%
Ins Owners1.07%
Ins Owner Change-0.25%
Market Cap23.35B
Analysts76.43
Price Target19.51 (21.48%)
Short Float %3.27%
Short Ratio2.72
Dividend
Industry RankSector Rank
Dividend Yield 3.78%
Yearly Dividend0.72
Dividend Growth(5Y)5.35%
DP68.97%
Div Incr Years0
Div Non Decr Years15
Ex-Date03-18 2025-03-18 (0.155)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.59%
Min EPS beat(2)4.87%
Max EPS beat(2)8.31%
EPS beat(4)4
Avg EPS beat(4)8.23%
Min EPS beat(4)4.87%
Max EPS beat(4)9.94%
EPS beat(8)8
Avg EPS beat(8)6.22%
EPS beat(12)9
Avg EPS beat(12)1.85%
EPS beat(16)11
Avg EPS beat(16)2.27%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.99%
Max Revenue beat(4)-0.63%
Revenue beat(8)1
Avg Revenue beat(8)-1.1%
Revenue beat(12)3
Avg Revenue beat(12)-1.08%
Revenue beat(16)4
Avg Revenue beat(16)-0.66%
PT rev (1m)2.38%
PT rev (3m)7.66%
EPS NQ rev (1m)3.41%
EPS NQ rev (3m)3.41%
EPS NY rev (1m)3.99%
EPS NY rev (3m)4.5%
Revenue NQ rev (1m)0.94%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)0.97%
Revenue NY rev (3m)2.01%
Valuation
Industry RankSector Rank
PE 12.85
Fwd PE 11.28
P/S 3.26
P/FCF 22.17
P/OCF 19
P/B 1.13
P/tB 1.62
EV/EBITDA N/A
EPS(TTM)1.25
EY7.78%
EPS(NY)1.42
Fwd EY8.87%
FCF(TTM)0.72
FCFY4.51%
OCF(TTM)0.85
OCFY5.26%
SpS4.92
BVpS14.18
TBVpS9.91
PEG (NY)0.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 7.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.22%
GM N/A
FCFM 14.72%
ROA(3y)1%
ROA(5y)0.85%
ROE(3y)10.17%
ROE(5y)8.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y8.21%
PM growth 5Y-3.17%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 11.2
Debt/EBITDA N/A
Cap/Depr 24.04%
Cap/Sales 2.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 69.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC13.56%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.71%
EPS 3Y-1.55%
EPS 5Y-0.32%
EPS Q2Q%13.33%
EPS Next Y13.92%
EPS Next 2Y13.3%
EPS Next 3Y13.25%
EPS Next 5Y6%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y7.22%
Revenue growth 5Y9.61%
Sales Q2Q%13.63%
Revenue Next Year7.18%
Revenue Next 2Y6.69%
Revenue Next 3Y6.2%
Revenue Next 5Y3.94%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-64.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.56%
OCF growth 3YN/A
OCF growth 5YN/A